المؤلفون: Matthias Schwab, Andrew Chan, Anna-Katharina Eser, Boris Kallmann, Dieter Pöhlau, Joachim Richter, Torsten B. Wagner, Christoph Grothe

المصدر: Neurology and Therapy, Vol 13, Iss 3, Pp 641-653 (2024)

مصطلحات موضوعية: Interferon beta-1a sc, Subcutaneous injection, Adherence, Patient support program, Multiple sclerosis, Neurology. Diseases of the nervous system, RC346-429

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2193-8253Test; https://doaj.org/toc/2193-6536Test

الوصول الحر: https://doaj.org/article/37e20567ddba4394b0fa4dbb255d5e11Test

المؤلفون: Heinz Wiendl, Ralf Gold, Thomas Berger, Tobias Derfuss, Ralf Linker, Mathias Mäurer, Orhan Aktas, Karl Baum, Martin Berghoff, Stefan Bittner, Andrew Chan, Adam Czaplinski, Florian Deisenhammer, Franziska Di Pauli, Renaud Du Pasquier, Christian Enzinger, Elisabeth Fertl, Achim Gass, Klaus Gehring, Claudio Gobbi, Norbert Goebels, Michael Guger, Aiden Haghikia, Hans-Peter Hartung, Fedor Heidenreich, Olaf Hoffmann, Boris Kallmann, Christoph Kleinschnitz, Luisa Klotz, Verena I. Leussink, Fritz Leutmezer, Volker Limmroth, Jan D. Lünemann, Andreas Lutterotti, Sven G. Meuth, Uta Meyding-Lamadé, Michael Platten, Peter Rieckmann, Stephan Schmidt, Hayrettin Tumani, Frank Weber, Martin S. Weber, Uwe K. Zettl, Tjalf Ziemssen, Frauke Zipp

المصدر: Therapeutic Advances in Neurological Disorders, Vol 14 (2021)

مصطلحات موضوعية: Neurology. Diseases of the nervous system, RC346-429

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1756-2864Test

الوصول الحر: https://doaj.org/article/cee55fa870514dd8bb41f4326e4ce63eTest

المؤلفون: Stephan Schmidt, Jürgen Koehler, Christine Winterstein, Petra Schicklmaier, Boris Kallmann

المصدر: Therapeutic Advances in Neurological Disorders, Vol 11 (2018)

مصطلحات موضوعية: Neurology. Diseases of the nervous system, RC346-429

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1756-2864Test

الوصول الحر: https://doaj.org/article/ab987bd903f24cffaff5a5ea2020fa6fTest

المؤلفون: Sven G Meuth, Antonios Bayas, Boris Kallmann, Ralf Linker, Peter Rieckmann, Mike P Wattjes, Mathias Mäurer, Christoph Kleinschnitz

المصدر: Expert opinion on pharmacotherapy. 23(13)

مصطلحات موضوعية: Pharmacology, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Medizin, Cladribine, Humans, Pharmacology (medical), General Medicine, ddc:610, Immunosuppressive Agents, Tablets

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74193d5171e97e3b597e0f21b939816aTest
https://pubmed.ncbi.nlm.nih.gov/35930260Test

المؤلفون: Martin S. Weber, Stefan Bittner, Claudio Gobbi, Hayrettin Tumani, Renaud Du Pasquier, Fedor Heidenreich, Ralf A. Linker, Frank Weber, Michael Platten, Martin Stangel, Andrew T. Chan, Heinz Wiendl, Olaf Hoffmann, Thomas Berger, Christian Enzinger, die Multiple Sklerose Therapie Konsensus Gruppe, Elisabeth Fertl, Mathias Mäurer, Orhan Aktas, Uwe K. Zettl, Ralf Gold, Boris Kallmann, Christoph Kleinschnitz, Florian Deisenhammer, Fritz Leutmezer, Jan D. Lünemann, Volker Limmroth, Zoë R. Hunter, Klaus Gehring, Aiden Haghikia, Verena I. Leussink, Franziska Di Pauli, Martin Berghoff, Michael Guger, Luisa Klotz, Tobias Derfuss, Tjalf Ziemssen, Stephan Schmidt, Uta Meyding-Lamadé, Hans-Peter Hartung, Sven G. Meuth, Frauke Zipp, Karl Baum, Achim Gass, Peter Rieckmann, Adam Czaplinski, Norbert Goebels, Andreas Lutterotti

المصدر: Der Nervenarzt

مصطلحات موضوعية: 0301 basic medicine, Central Nervous System, medicine.medical_specialty, Early therapeutic intervention, Neurology, Consensus, Multiple Sclerosis, Disease, Guideline, Behandlungsempfehlung, 03 medical and health sciences, 0302 clinical medicine, Germany, medicine, Humans, Intensive care medicine, Leitlinie, business.industry, Multiple sclerosis, Psychosomatic medicine, General Medicine, medicine.disease, Autoimmune-mediated disease, Immuntherapie, Europe, Psychiatry and Mental health, 030104 developmental biology, Position paper, Konsensuspapiere, Neurology (clinical), Neurosurgery, Psychopharmacology, Immunotherapy, business, Treatment recommendation, 030217 neurology & neurosurgery, Autoimmunerkrankung, Frühe Therapieintervention

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::150a5aeb37085c6f2116878af90b499bTest
http://europepmc.org/articles/PMC8300076Test

المؤلفون: Ralf A. Linker, Karl Baum, Michael Guger, Fritz Leutmezer, Stefan Bittner, Martin Stangel, Orhan Aktas, Fedor Heidenreich, Claudio Gobbi, Hans-Peter Hartung, Franziska Di Pauli, Martin Berghoff, Mathias Mäurer, Frauke Zipp, Christoph Kleinschnitz, Thomas Berger, Achim Gass, Elisabeth Fertl, Aiden Haghikia, Verena I. Leussink, Adam Czaplinski, Tobias Derfuss, Norbert Goebels, Martin S. Weber, Christian Enzinger, Uta Meyding-Lamadé, A. Chan, Luisa Klotz, Volker Limmroth, Frank Weber, Boris Kallmann, H. Wiendl, Tjalf Ziemssen, P. Rieckmann, Hayrettin Tumani, Jan D. Lünemann, Klaus Gehring, Uwe K. Zettl, Multiple Sklerose Therapie Konsensus Gruppe, Renaud Du Pasquier, F. Deisenhammer, Olaf Hoffmann, Stephan Schmidt, Andreas Lutterotti, Ralf Gold, Michael Platten, Sven G. Meuth

المصدر: DGNeurologie

مصطلحات موضوعية: Gynecology, medicine.medical_specialty, business.industry, medicine, Leserbriefe, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37bee8f803b1276342c212081ecd2e45Test
http://europepmc.org/articles/PMC8207810Test

المؤلفون: Stefan Ries, Ulrich Engelmann, Jennifer S Kullmann, Boris Kallmann, Laura M Quint, Andrew T. Chan

المصدر: Kallmann, Boris A; Ries, Stefan; Kullmann, Jennifer S; Quint, Laura M; Engelmann, Ulrich; Chan, Andrew (2021). Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment status. Therapeutic advances in neurological disorders, 14, p. 17562864211005588. Sage 10.1177/17562864211005588 <http://dx.doi.org/10.1177/17562864211005588Test>
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Therapeutic Advances in Neurological Disorders

مصطلحات موضوعية: 0301 basic medicine, Pre treatment, medicine.medical_specialty, 610 Medicine & health, multiple sclerosis, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Teriflunomide, medicine, observational, RC346-429, Original Research, Pharmacology, immunosenescence, treatment, business.industry, Multiple sclerosis, satisfaction, Immunosenescence, medicine.disease, pre-treatment, switch, 030104 developmental biology, Neurology, chemistry, Relapsing remitting, age, Observational study, Neurology (clinical), Neurology. Diseases of the nervous system, Once daily, business, 030217 neurology & neurosurgery

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75354bdb730ef84846d2d7012b1034a2Test
https://boris.unibe.ch/157488/1/Kallmann__2021__Teriflunomide_in_relapsing_remitting_MS.pdf

المؤلفون: Ralf A. Linker, Antonios Bayas, Christoph Kleinschnitz, Boris Kallmann, Sven G. Meuth, Peter Rieckmann, Mathias Mäurer

مصطلحات موضوعية: medicine.medical_specialty, Multiple Sclerosis, Medizin, Administration, Oral, Drug Administration Schedule, Disease course, 03 medical and health sciences, 0302 clinical medicine, Multiple Sclerosis, Relapsing-Remitting, Recurrence, Long term management, Medicine, Humans, Pharmacology (medical), Cladribine, Intensive care medicine, Expert Testimony, Pharmacology, Clinical Trials as Topic, business.industry, Multiple sclerosis, General Medicine, medicine.disease, Treatment Outcome, 030220 oncology & carcinogenesis, Expert opinion, Practice Guidelines as Topic, Drug Monitoring, business, 030217 neurology & neurosurgery, Immunosuppressive Agents, medicine.drug, Tablets

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a821c53ff672bd25c658388fef046f56Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85087944395Test

المؤلفون: Christoph Kleinschnitz, Boris Kallmann, Frank Weber, Florian Deisenhammer, Hayrettin Tumani, Michael Platten, Luisa Klotz, Fedor Heidenreich, Karl Baum, Uwe K. Zettl, Tjalf Ziemssen, Ralf A. Linker, H. Wiendl, Stephan Schmidt, Sven G. Meuth, Christian Enzinger, Stefan Bittner, Elisabeth Fertl, Verena I. Leussink, Volker Limmroth, Renaud Du Pasquier, Franziska Di Pauli, Michael Guger, Martin Berghoff, Uta Meyding-Lamadé, Achim Gass, Adam Czaplinski, Hans-Peter Hartung, Peter Rieckmann, Norbert Goebels, Klaus Gehring, Aiden Haghikia, Olaf Hoffmann, Mathias Mäurer, Tobias Derfuss, Frauke Zipp, Thomas Berger, Fritz Leutmezer, Martin S. Weber, Orhan Aktas, Ralf Gold, Jan D. Lünemann, Andreas Lutterotti, Andrew T. Chan, Claudio Gobbi

المصدر: Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Wiendl, Heinz; Gold, Ralf; Berger, Thomas; Derfuss, Tobias; Linker, Ralf; Mäurer, Mathias; Aktas, Orhan; Baum, Karl; Berghoff, Martin; Bittner, Stefan; Chan, Andrew; Czaplinski, Adam; Deisenhammer, Florian; Di Pauli, Franziska; Du Pasquier, Renaud; Enzinger, Christian; Fertl, Elisabeth; Gass, Achim; Gehring, Klaus; Gobbi, Claudio; ... (2021). Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Therapeutic advances in neurological disorders, 14, p. 17562864211039648. Sage 10.1177/17562864211039648 <http://dx.doi.org/10.1177/17562864211039648Test>
Therapeutic Advances in Neurological Disorders

مصطلحات موضوعية: Position statement, medicine.medical_specialty, treatment recommendation, Medizin, 610 Medicine & health, Review, Disease, multiple sclerosis, 03 medical and health sciences, 0302 clinical medicine, White paper, Neuronal damage, medicine, 030212 general & internal medicine, RC346-429, Intensive care medicine, Pharmacology, business.industry, Multiple sclerosis, Disease mechanisms, Guideline, medicine.disease, disease-modifying therapy, 3. Good health, Group treatment, Neurology, Neurology. Diseases of the nervous system, Neurology (clinical), business, guideline, 030217 neurology & neurosurgery

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c28d2b49594a84a85cdda6e5ad9727b7Test
https://doi.org/10.1177/17562864211039648Test

المؤلفون: Jürgen Koehler, Christine Winterstein, Stephan Schmidt, Petra Schicklmaier, Boris Kallmann

المصدر: Therapeutic Advances in Neurological Disorders, Vol 11 (2018)
Therapeutic Advances in Neurological Disorders

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Multiple Sclerosis, First line, Disease, Treatment goals, NEDA, lcsh:RC346-429, Disease course, Disease activity, treatment optimization, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Epidemiology, medicine, Disease-modifying therapies, lcsh:Neurology. Diseases of the nervous system, Original Research, Pharmacology, business.industry, Multiple sclerosis, medicine.disease, 030104 developmental biology, Neurology, Relapsing remitting, Neurology (clinical), business, 030217 neurology & neurosurgery

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bf610930f1072588885f2aee39a220dTest
https://doaj.org/article/ab987bd903f24cffaff5a5ea2020fa6fTest